Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

Journal of Experimental Medicine

Volumn 190, Issue 4, 1999, Pages 567-576

  Babcock, Gregory J ^a   Decker, Lisa L ^a   Freeman, Richard B ^b   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

B cell; Epstein Barr virus; Immunosuppression; Latency

Indexed keywords

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BLOOD; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOBLAST; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; VIRUS LOAD;

B-LYMPHOCYTES; CELL CYCLE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; LYMPHOMA, AIDS-RELATED; LYMPHOPROLIFERATIVE DISORDERS; MONITORING, IMMUNOLOGIC; ORGAN TRANSPLANTATION; PHENOTYPE; PLASMIDS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRAL MATRIX PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0033575762     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.4.567     Document Type: Article

References (29)

1. Rickinson, A.B., and E. Kieff. 1996. Epstein-Barr virus. In Virology, Vol. 2, 3rd. ed. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. 2 vols. Raven Press, New York. 2397-2446.
2. Kieff, E. 1996. Epstein-Barr virus and its replication. In Virology, Vol. 2, 2nd. ed. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. 2 vols. Raven Press, New York. 2343-2396.
3. Yao, Q.Y., A.B. Rickinson, and M.A. Epstein. 1985. A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer. 35:35-42.
4. Khan, G., E.M. Miyashita, B. Yang, G.J. Babcock, and D.A. Thorley-Lawson. 1996. Is EBV persistence in vivo a model for B cell homeostasis? Immunity. 5:173-179.
5. Decker, L.L., L.D. Klaman, and D.A. Thorley-Lawson. 1996. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70:3286-3289.
6. Babcock, G.J., L.L. Decker, M. Volk, and D.A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity. 9:395-404.
7. Qu, L., and D.T. Rowe. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:3715-3724.
8. Miyashita, E.M., B. Yang, K.M. Lam, D.H. Crawford, and D.A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:593-601.
9. Miyashita, E.M., B. Yang, G.J. Babcock, and D.A. Thorley-Lawson. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71:4882-4891.
10. Thorley-Lawson, D.A. 1998. EBV persistence in vivo. Invading and avoiding the immune response. In Herpesviruses and Immunity. P.G. Medveczky, H. Friedman, and M. Bendinelli, editors. Plenum Press, New York. 207-229.
11. Kenagy, D.N., Y. Schlesinger, K. Weck, J.H. Ritter, M.M. Gaudreault-Keener, and G.A. Storch. 1995. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation. 60:547-554.
12. Lam, K.M., N. Syed, H. Whittle, and D.H. Crawford. 1991. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet. 337:876-878.
13. Martinez, O.M., J.C. Villanueva, L. Lawrence-Miyasaki, M.B. Quinn, R. Gish, K. Cox, S. So, C.O. Esquivel, and S.M. Krams. 1995. Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Transplant Proc. 27:1211-1212.
14. McKnight, J.L., H. Cen, S.A. Riddler, M.C. Breinig, P.A. Williams, M. Ho, and P.S. Joseph. 1994. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease. Leuk. Lymphoma. 15:9-16.
15. Telenti, A., W.F. Marshall, and T.F. Smith. 1990. Detection of Epstein-Barr virus by polymerase chain reaction. J. Clin. Microbiol. 28:2187-2190.
16. Yao, Q.Y., A.B. Rickinson, J.S. Gaston, and M.A. Epstein. 1985. In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients. Int. J. Cancer. 35:43-49.
17. Lewin, N., P. Aman, M.G. Masucci, E. Klein, G. Klein, B. Oberg, H. Strander, W. Henle, and G. Henle. 1987. Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int. J. Cancer. 39: 472-476.
18. Khanna, R., S.R. Burrows, and D.J. Moss. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:387-405.
19. Starzl, T.E., M.A. Nalesnik, K.A. Porter, M. Ho, S. Iwatsuki, B.P. Griffith, J.T. Rosenthal, T.R. Hakala, B.W. Shaw, Jr., R.L. Hardesty, et al. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporinsteroid therapy. Lancet. 1:583-587.
20. Hornef, M.W., H.J. Wagner, L. Fricke, G. Bein, and H. Kirchner. 1995. Immunocytochemical detection of Epstein-Barr virus antigens in peripheral B lymphocytes after renal transplantation. Transplantation. 59:138-140.
21. Schaefer, B.C., J.L. Strominger, and S.H. Speck. 1996. A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle. J. Virol. 70:8204-8208.
22. Chen, F., J.Z. Zou, L. di Renzo, G. Winberg, L.F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol 69:3752-3758.
23. Tierney, R.J., N. Steven, L.S. Young, and A.B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
24. Summers, W.C., and G. Klein. 1976. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J. Virol. 18:151-155.
25. Beaufils, P., D. Choquet, R.Z. Mamoun, and B. Malissen. 1993. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO (Eur. Mol. Biol. Organ.) J. 12:5105-5112.
26. Knowles, D.M., E. Cesarman, A. Chadburn, G. Frizzera, J. Chen, E.A. Rose, and R.E. Michler. 1995. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 85:552-565.
27. Khanna, R., R.W. Slade, L. Poulsen, D.J. Moss, S.R, Burrows, J. Nicholls, and J.M. Burrows. 1997. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J. Virol. 71:8340-8346.
28. Prang, N.S., M.W. Hornef, M. Jager, H.J. Wagner, H. Wolf, and F.M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood. 89:1665-1677.
29. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69:4872-4879.